Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSCW) Other Non-Current Liabilities (2021 - 2025)

Historic Other Non-Current Liabilities for Ensysce Biosciences (ENSCW) over the last 5 years, with Q3 2025 value amounting to $35.0.

  • Ensysce Biosciences' Other Non-Current Liabilities changed N/A to $35.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0, marking a year-over-year change of. This contributed to the annual value of $10096.0 for FY2024, which is 6174.02% down from last year.
  • As of Q3 2025, Ensysce Biosciences' Other Non-Current Liabilities stood at $35.0.
  • Ensysce Biosciences' Other Non-Current Liabilities' 5-year high stood at $3.7 million during Q4 2021, with a 5-year trough of $35.0 in Q3 2025.
  • Over the past 5 years, Ensysce Biosciences' median Other Non-Current Liabilities value was $310346.0 (recorded in 2022), while the average stood at $703182.0.
  • Examining YoY changes over the last 5 years, Ensysce Biosciences' Other Non-Current Liabilities showed a top increase of 4782.47% in 2022 and a maximum decrease of 9150.39% in 2022.
  • Over the past 5 years, Ensysce Biosciences' Other Non-Current Liabilities (Quarter) stood at $3.7 million in 2021, then tumbled by 91.5% to $310346.0 in 2022, then crashed by 91.5% to $26388.0 in 2023, then crashed by 61.74% to $10096.0 in 2024, then crashed by 99.65% to $35.0 in 2025.
  • Its last three reported values are $35.0 in Q3 2025, $1033.0 for Q2 2025, and $130180.0 during Q1 2025.